Coperion K-Tron, Hosokawa and Sly Inc. Offer Milling and Material Handling Seminar - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Coperion K-Tron, Hosokawa and Sly Inc. Offer Milling and Material Handling Seminar


Coperion K-Tron, together with Hosokawa Powder Micron Systems and Sly, Inc., are hosting a complimentary, in-house demonstration on milling and material handling for pharmaceutical and and other applications on Oct. 14-15 at Hosokawa’s Summit, NJ facility.

Coperion K-Tron is presenting on key topics and trends related to ingredient feeding and material handling, offering a technical objective overview on methods of both improving current operations and utilizing new process technologies in feeding and sanitary pneumatic conveying of powder and bulk materials. The seminar gives guests the opportunity to participate in live milling demonstrations and hands-on access to ancillary equipment including Coperion K-Tron’s new MT12/MT16 Micro-ingredient Feeder.

The seminar is suitable for process engineers and equipment operators interested in air classifying mills, ingredient feeders, granulators, hammer mills, sanitary pneumatic conveying, pin mills, or dust collection systems.

Source: Sly Inc.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here